ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Isomorphic Labs, an Alphabet spinoff, talks a $40 billion to $50 billion funding round. The company previously inked deals worth nearly $3 billion with Eli Lilly and Novartis in 2024 and launched a collaboration with Johnson & Johnson this past January.
Tracked by ByteBrief